Pulmonary diseases: when the profession is a risk
Many professions carry the risk of developing pulmonary diseases. The lungs are organs with an extensive surface area, high vascularity, and a thin barrier between air and blood. This structure makes them a contact site for environmental agents, many of which have local and/or systemic or immunological toxic effects. Exposures to toxic substances can cause […]
Diagnosis of Asthma: Challenges and Solutions
The diagnosis of asthma is an urgent need for two main reasons. The first is that it is estimated to affect 300 million people worldwide. And the second is that asthma treatment generates high costs for healthcare institutions and patients.1 Although current asthma guidelines use both clinical criteria and spirometry-based criteria to define the severity […]
The crucial role of spirometry to enhance lung health
Spirometry is fundamental in the assessment of overall pulmonary function. It allows analyzing the impact on lung function caused by various diseases, evaluating the airways’ response to medical treatment, monitoring the disease’s progression, or the outcome of therapeutic interventions, and determining the prognosis for many pulmonary conditions. In this article, we will discuss occupational lung […]
Clinical Advances in Pulmonary Health 2023
The constant search for innovative solutions and more effective treatments has led to significant progress in the research of pulmonary diseases, marking a milestone in the understanding and clinical approach to these medical conditions. In this blog, we highlight some of the milestones reached in pulmonary health research. We mention some of the most notable […]
LFX Software: SCHILLER’s Solution for Pulmonary Function Testing
SCHILLER- GANSHORN‘s LFX software is a comprehensive solution for pulmonary function testing that can make a significant difference in the care of patients with respiratory conditions. It is a user-friendly patient management platform that provides healthcare professionals with sophisticated tools to conduct high-quality lung assessments. At SCHILLER- GANSHORN, we understand the importance of accurate pulmonary […]
Clinical Benefits of Oscillometry in Respiratory Assessment
Oscillometry is a non-invasive method to measure the mechanical properties of the respiratory system. This diagnostic tool enhances the valuable contributions of spirometry for the diagnosis, assessment, and monitoring of respiratory diseases such as asthma and COPD. In this article, we will discuss the clinical advantages of oscillometry as a complementary method to spirometry. We […]
Asthma: Exploring its Impactful Figures
According to the GINA Guide 2019, asthma is estimated to affect 300 million people worldwide. In fact, it is one of the most common and costly diseases in the United States. It consists of diffuse inflammation of the airways caused by various stimuli, which cause a partial or completely reversible bronchoconstriction. Symptoms and signs include […]
The GINA Guide 2022: summary of the main updates for asthma management
Keeping up with the latest advancements in the field of pulmonology is key for providing optimal care to patients, particularly those suffering from asthma. In this blog post, we make a summary of the recently updated 2022 Global Initiative for Asthma (GINA) Guide, highlighting key changes and advancements that pulmonologists need to be aware of. […]
ATS Adopts Race-Neutral Spirometry Interpretation
The American Thoracic Society (ATS) removed race and ethnicity from spirometry interpretation. They announced this official change just weeks after the Global Initiative for Chronic Obstructive Lung Disease (GOLD) released its 2023 Report, which still includes these demographic factors in its evaluation criteria. The ATS‘s panel of authors remarked that the change was necessary. They […]
GOLD Report 2023: Key COPD Guideline Updates for Clinicians
The GOLD Report 2023 includes 387 new references, updates for the diagnosis and treatment of COPD, reclassifies patients into three groups, and makes changes to initial medications by patient group, among many other things. We prepared for you a summary of some of the main updates in the 2023 GOLD COPD Guidelines, a Clinical Practice […]